Opicapone vs Co-beneldopa (Benserazide/levodopa)
National NHS prescribing compared (Prescription Cost Analysis)
Co-beneldopa (Benserazide/levodopa) was dispensed 10.6× as often as Opicapone in May 2026 — 77,476 items versus 7,291 in England.
7,291items
Opicapone · May 2026
NHSBSA Prescription Cost Analysis
77,476items
Co-beneldopa (Benserazide/levodopa) · May 2026
NHSBSA Prescription Cost Analysis
Figure 1. Opicapone versus Co-beneldopa (Benserazide/levodopa): national items dispensed by month
▬ Opicapone · ╌ Co-beneldopa (Benserazide/levodopa)
Source: NHSBSA Prescription Cost Analysis, to May 2026
| Measure | Opicapone | Co-beneldopa (Benserazide/levodopa) |
|---|---|---|
| Items, May 2026 | 7,291 | 77,476 |
| Items, last 12 months | 84,243 | 948,791 |
| Net ingredient cost, May 2026 | £423,746 | £953,642 |
See the full profile for Opicapone or Co-beneldopa (Benserazide/levodopa).